The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2020

Filed:

Apr. 24, 2015
Applicant:

Wisconsin Alumni Research Foundation, Madison, WI (US);

Inventors:

Sandro Mecozzi, Madison, WI (US);

Robert A. Pearce, Madison, WI (US);

William Tucker, Madison, WI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/107 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61K 31/05 (2006.01); A61K 31/57 (2006.01); A61K 31/685 (2006.01); A61K 31/755 (2006.01); A61K 47/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1075 (2013.01); A61K 9/0019 (2013.01); A61K 31/05 (2013.01); A61K 31/57 (2013.01); A61K 31/685 (2013.01); A61K 31/755 (2013.01); A61K 47/06 (2013.01); A61K 47/34 (2013.01);
Abstract

The present invention provides therapeutic formulations, including therapeutic nanoemulsions, and related methods for the in vivo delivery of hydrophobic compounds, including an important class of hydrophobic anesthetics. Formulations and methods of the invention include semifluorinated block copolymers and perhalogenated fluorous compounds, such as perfluorooctyl bromide or perfluorodecalin, capable of forming a stable nanoemulsion without the need of conventional lipid components that support bacterial and/or fungal growth (e.g., soybean oil and similar lipids). In certain embodiments, emulsion-based formulations are provided that are capable of formulating, delivering and releasing amounts of hydrophobic drugs effective for a range of clinical applications, including inducing and maintaining anesthesia in patients. In certain embodiments, emulsion-based formulations are provided that are capable of supporting controlled release, for example, over a range of rates useful for clinical applications including rapid and sustained release.


Find Patent Forward Citations

Loading…